PRKCE and familial dilated cardiomyopathy: Activation of PKCε reduces ventricular dilation and hypertrophy but does not rescue contractile dysfunction in the cTnTR141W transgenic mouse model of DCM (Lu et al., 2014), suggesting that PKCε may partially ameliorate pathological cardiac remodeling in some forms of DCM.